comparemela.com

Latest Breaking News On - Global generics - Page 10 : comparemela.com

Dr Reddy s Laboratories posts decent Q2 results as US sales stabilize – RTN asia

Dr Reddy s Laboratories posts decent Q2 results as US sales stabilize – RTN asia
rtn.asia - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rtn.asia Daily Mail and Mail on Sunday newspapers.

Dr Reddy s Q2 Results: Profit rises 30% to Rs 1482 20 crore, beats estimates - Industry News

Dr Reddy s Q2 Results: Profit rises 30% to Rs 1482 20 crore, beats estimates - Industry News
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Dr Reddy s Laboratories Limited (NYSE:RDY) Receives Average Recommendation of Hold from Brokerages

Shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY – Get Free Report) have been assigned a consensus recommendation of “Hold” from the six ratings firms that are currently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and two have given a […]

Brokerages Set Dr Reddy s Laboratories Limited (NYSE:RDY) Target Price at $70 00

Dr. Reddy’s Laboratories Limited (NYSE:RDY – Get Free Report) has earned an average rating of “Hold” from the six ratings firms that are presently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and two have given a buy recommendation […]

Head to Head Analysis: LAVA Therapeutics (NASDAQ:LVTX) versus Dr Reddy s Laboratories (NYSE:RDY)

LAVA Therapeutics (NASDAQ:LVTX – Get Free Report) and Dr. Reddy’s Laboratories (NYSE:RDY – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability and risk. Earnings & Valuation This table compares LAVA […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.